Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc (KOD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 649,425
  • Shares Outstanding, K 51,954
  • Annual Sales, $ 0 K
  • Annual Income, $ -266,990 K
  • 60-Month Beta 1.89
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.95
Trade KOD with:

Options Overview Details

View History
  • Implied Volatility 86.05% ( -27.80%)
  • Historical Volatility 106.07%
  • IV Percentile 38%
  • IV Rank 11.40%
  • IV High 290.67% on 02/22/22
  • IV Low 59.72% on 10/28/21
  • Put/Call Vol Ratio 0.17
  • Today's Volume 1,944
  • Volume Avg (30-Day) 2,331
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 38,922
  • Open Int (30-Day) 17,736

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.77
  • Number of Estimates 4
  • High Estimate -1.56
  • Low Estimate -1.92
  • Prior Year -1.30
  • Growth Rate Est. (year over year) -36.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.89 +49.18%
on 08/02/22
12.80 -8.05%
on 08/11/22
+3.05 (+34.98%)
since 07/11/22
3-Month
4.90 +140.20%
on 05/12/22
12.80 -8.05%
on 08/11/22
+6.74 (+133.76%)
since 05/11/22
52-Week
4.90 +140.20%
on 05/12/22
26.39 -55.41%
on 11/05/21
-5.85 (-33.22%)
since 08/11/21

Most Recent Stories

More News
Kodiak Sciences (KOD) Q2 Earnings Beat, Eye Candidate in Focus

Kodiak Sciences (KOD) reports narrower-than-expected loss for the second quarter of 2022. The focus is on the lead candidate, KSI-301, which is being developed for treating various retinal vascular diseases....

REGN : 623.90 (-2.74%)
BAYRY : 13.3300 (-0.15%)
KOD : 11.77 (-5.84%)
DTIL : 1.6300 (-1.21%)
Kodiak Sciences Announces Second Quarter 2022 Financial Results and Recent Business Highlights

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

KOD : 11.77 (-5.84%)
Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD) today announced that its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab), its novel...

KOD : 11.77 (-5.84%)
Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

KOD : 11.77 (-5.84%)
Why Kodiak Sciences Stock Is Sharply Lower Today

An analyst downgrade is weighing on the drugmaker's stock price today.

C : 54.00 (+1.52%)
KOD : 11.77 (-5.84%)
Why Is Kodiak Sciences Inc. (KOD) Up 88.3% Since Last Earnings Report?

Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

KOD : 11.77 (-5.84%)
FATE : 32.65 (+0.71%)
Kodiak Sciences (KOD) Q1 Loss Widens, Eye Candidate in Focus

Kodiak Sciences (KOD) reports wider-than-expected loss in the first quarter of 2022. Focus is on lead candidate, KSI-301, being developed for treating various retinal vascular diseases.

REGN : 623.90 (-2.74%)
BAYRY : 13.3300 (-0.15%)
KOD : 11.77 (-5.84%)
FULC : 7.57 (-2.45%)
Should You Buy Kodiak (KOD) Ahead of Earnings?

Kodiak (KOD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

KOD : 11.77 (-5.84%)
Kodiak Sciences Enters Oversold Territory (KOD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

KOD : 11.77 (-5.84%)
Why Is Kodiak Sciences Inc. (KOD) Down 12.7% Since Last Earnings Report?

Kodiak Sciences Inc. (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

KOD : 11.77 (-5.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Kodiak Sciences Inc. is a clinical stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic, high-prevalence retinal diseases, which are the major causes of blindness. The company's proprietary antibody biopolymer conjugate (ABC) platform is designed to maintain potent...

See More

Key Turning Points

3rd Resistance Point 14.11
2nd Resistance Point 13.46
1st Resistance Point 12.61
Last Price 11.77
1st Support Level 11.11
2nd Support Level 10.46
3rd Support Level 9.61

See More

52-Week High 26.39
Fibonacci 61.8% 18.18
Fibonacci 50% 15.65
Fibonacci 38.2% 13.11
Last Price 11.77
52-Week Low 4.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar